Jiayuh Lin Selected Research

Jiayuh Lin Research Topics

Disease

76	Neoplasms (Cancer) 05/2022 - 01/2002
25	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
16	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 07/2009
8	Carcinogenesis 01/2021 - 09/2005
8	Rhabdomyosarcoma 01/2017 - 06/2007
7	Neoplasm Metastasis (Metastasis) 03/2021 - 09/2005
7	Colonic Neoplasms (Colon Cancer) 08/2019 - 12/2011
7	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 08/2010
6	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 04/2004
6	Inflammation (Inflammations) 02/2021 - 08/2010
6	Liver Neoplasms (Liver Cancer) 08/2017 - 08/2010
6	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 06/2007
5	Medulloblastoma 01/2021 - 02/2015
4	Triple Negative Breast Neoplasms 05/2020 - 11/2018
4	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 04/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2012 - 05/2002
3	Colorectal Neoplasms (Colorectal Cancer) 02/2019 - 03/2009
3	Leukemia 01/2012 - 04/2004
3	Glioblastoma (Glioblastoma Multiforme) 09/2010 - 01/2010
2	Atherosclerosis 02/2021 - 11/2020
2	Osteoporosis 02/2021 - 01/2017
2	Abdominal Aortic Aneurysm 01/2020 - 01/2018
2	Multiple Myeloma 01/2017 - 08/2010
2	Stomach Neoplasms (Stomach Cancer) 01/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2012 - 06/2010
1	Atherosclerotic Plaque (Atheroma) 02/2021
1	Heart Failure 01/2021
1	Hypertrophy 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Fibrosis (Cirrhosis) 01/2021

Drug/Important Bio-Agent (IBA)

41	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 01/2002
30	Interleukin-6 (Interleukin 6)IBA 05/2021 - 10/2008
14	bazedoxifeneIBA 05/2022 - 01/2016
14	CurcuminIBA 01/2012 - 02/2009
12	Pharmaceutical PreparationsIBA 01/2019 - 03/2010
11	FLLL 32IBA 03/2016 - 03/2010
10	CytokinesIBA 01/2022 - 06/2010
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
9	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 04/2004
9	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 01/2002
8	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 05/2002
7	SurvivinIBA 05/2022 - 09/2005
7	Transcription Factors (Transcription Factor)IBA 03/2021 - 10/2009
6	Phosphotransferases (Kinase)IBA 05/2021 - 04/2004
6	Caspase 3 (Caspase-3)IBA 10/2013 - 03/2009
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 11/2016
5	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2004
4	Raloxifene Hydrochloride (Evista)FDA Link 01/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 09/2005
4	Biological ProductsIBA 02/2018 - 12/2012
4	Aldehyde DehydrogenaseIBA 12/2016 - 12/2011
3	ApolipoproteinsIBA 02/2021 - 01/2018
3	Cyclin D1IBA 01/2021 - 07/2011
3	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2002
3	Glycoproteins (Glycoprotein)IBA 01/2020 - 03/2019
3	Estrogen ReceptorsIBA 06/2019 - 09/2005
3	Gemcitabine FDA Link 01/2019 - 03/2016
3	Ursolic AcidIBA 01/2018 - 10/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 03/2010
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 12/2013
3	AZD 6244IBA 01/2016 - 12/2013
3	STA-21IBA 10/2008 - 03/2005
2	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA 05/2022 - 07/2018
2	ChemokinesIBA 01/2022 - 07/2018
2	Apolipoproteins E (ApoE)IBA 02/2021 - 11/2020
2	PlatinumIBA 01/2021 - 01/2020
2	ElastinIBA 01/2020 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 09/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2019 - 09/2005
2	InterleukinsIBA 03/2019 - 07/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2019 - 01/2019
2	Interleukin-11 (Interleukin 11)IBA 02/2019 - 11/2016
2	Bromodeoxyuridine (BrdU)IBA 02/2019 - 07/2018
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 09/2007
2	Dasatinib (BMS 354825)FDA Link 01/2019 - 01/2019
2	Interleukin-8 (Interleukin 8)IBA 11/2018 - 07/2018
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 12/2013
2	statticIBA 01/2013 - 12/2011
2	Annexin A5IBA 01/2012 - 06/2010
2	Celecoxib (Celebrex)FDA Link 08/2011 - 04/2011
2	AgarIBA 03/2010 - 09/2009
2	1,5- bis(3,5- bis(methoxymethoxy)phenyl)penta- 1,4- dien- 3- oneIBA 10/2009 - 03/2009
2	Janus Kinase 2IBA 08/2004 - 04/2004
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2022
1	AntigensIBA 01/2022
1	LigandsIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2021
1	talazoparibIBA 05/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	taxaneIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 10/2020
1	Phenobarbital (Luminal)FDA Link 05/2020

Therapy/Procedure

34	Therapeutics 05/2022 - 03/2002
9	Drug Therapy (Chemotherapy) 01/2021 - 03/2011
3	Chemoprevention 05/2017 - 01/2012
2	Oral Administration 06/2019 - 01/2017
1	Immunotherapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021